Maria Bech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Maria bech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Maria Bech Today - Breaking & Trending Today
EpiEndo Pharmaceuticals: EpiEndo reports Phase 2A results for lead asset, EP395, in COPD finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
REYKJAVIK, Iceland, April 10, 2024 EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), a clinical-stage biopharmaceutical company developing a new class of oral, barrier-enhancing, anti-inflammatory therapeutics addressing chronic airway diseases, announces the successful completion of its Phase 2A clinical trial for EP395 in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). ....
PAXMAN´s AGM was held today, 24 May 2023, at NetPort in Karlshamn. Almost 57 % of all issued shares were represented at the meeting. After the formal AGM, CEO Richard Paxman gave a company. | May 24, 2023 ....
Regulatory approval for first patient study of first non-antibiotic macrolideREYKJAVIK, Iceland, November 14, 2022 / B3C newswire / EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing therapeutics for chronic inflammatory diseases, has received regulatory approval to. ....
Regulatory approval for first patient study of first non-antibiotic macrolide EpiEndo Pharmaceuticals ('EpiEndo'), the clinical-stage biopharmaceutical company developing therapeutics for chronic ....